Hepatocellular carcinoma (HCC), which is a common malignancy worldwide, usually
develops in a cirrhotic liver due to hepatitis virus infection. Metabolic syndrome, which is …

Background Liver cancer is one of the common malignancies. The dysregulation of
metabolism is a driver of accelerated tumourigenesis. Metabolic changes are well …

The growing interest in cancer epigenetics is largely due to the reversible nature of
epigenetic changes which tend to alter during the course of carcinogenesis. Major …

Hepatocellular carcinoma (HCC) is a deadly disease and therapeutic efficacy in advanced
HCC is limited. Since progression of chronic liver disease to HCC involves a long latency …

Cancer is a heterogenous disease characterized by changes in the expression of multiple
genes caused by genetic alternations and epigenetic modifications. Studies of the changes …

Liver cancer is a severe concern for public health officials since the clinical cases are
increasing each year, with an estimated 5-year survival rate of 30%–35% after diagnosis …

Hepatocellular carcinoma (HCC), a primary liver malignancy, is one of the deadliest cancers
worldwide. Despite orthotopic liver transplantation and hepatic resection representing the …

Chemoprevention may be defined as the use of non-toxic substances, including many food
factors, to interfere with the process of cancer development or carcinogenesis before …

Epigenetic mechanisms maintain heritable changes in gene expression and chromatin
organization over many cell generations. Importantly, deregulated epigenetic mechanisms …

Liver cancer is among the most common malignancies, impacting significantly across all
societies worldwide. The lethal impact of this prevalent cancer is unlikely to change …